Their study suggested that the rs1050244 variant disrupted the interaction of both miR‐133a and miR‐197 with the DDB2 mRNA, leading to an upregulation of DDB2 expression and a potentially reduced risk of HCC [65]. The gene discussed is DDB2; the disease is hepatocellular carcinoma.